Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Asset Utilization Ratio (2020 - 2025)

Legend Biotech filings provide 6 years of Asset Utilization Ratio readings, the most recent being 0.6 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 62.08% to 0.6 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.6, a 62.08% increase, with the full-year FY2025 number at 0.6, up 69.56% from a year prior.
  • Asset Utilization Ratio hit 0.6 in Q4 2025 for Legend Biotech, up from 0.53 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 45.22 in Q3 2024 to a low of 0.0 in Q1 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.37 (2024), compared with a mean of 10.6.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 147728.61% in 2021 and later crashed 99.15% in 2024.
  • Legend Biotech's Asset Utilization Ratio stood at 0.09 in 2021, then grew by 25.53% to 0.12 in 2022, then soared by 36951.55% to 43.21 in 2023, then crashed by 99.15% to 0.37 in 2024, then surged by 62.08% to 0.6 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.6 (Q4 2025), 0.53 (Q3 2025), and 0.48 (Q2 2025) per Business Quant data.